LNA Santé SA

BATS-CHIXE:LNAP Stock Report

Market Cap: €329.4m

LNA Santé Past Earnings Performance

Past criteria checks 4/6

LNA Santé's earnings have been declining at an average annual rate of -6%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 7.6% per year. LNA Santé's return on equity is 9.3%, and it has net margins of 3.6%.

Key information

-6.0%

Earnings growth rate

-6.3%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate7.6%
Return on equity9.3%
Net Margin3.6%
Last Earnings Update30 Jun 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How LNA Santé makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BATS-CHIXE:LNAP Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2271126830
31 Mar 2270025820
31 Dec 2168924820
30 Sep 2166220780
30 Jun 2163416740
31 Mar 2160412700
31 Dec 205748670
30 Sep 2056210650
30 Jun 2055113640
31 Mar 2053917610
31 Dec 1952821590
30 Sep 1953121710
30 Jun 1953422830
31 Mar 1953622950
31 Dec 18539221070
30 Sep 18522231020
30 Jun 1850525960
31 Mar 1849625940
31 Dec 1748724930
30 Sep 1749224950
30 Jun 1749724980
31 Mar 1748623960
31 Dec 1647522940
30 Sep 1644917920
30 Jun 1642313910
31 Mar 1642412900

Quality Earnings: LNAP has high quality earnings.

Growing Profit Margin: LNAP's current net profit margins (3.6%) are higher than last year (2.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: LNAP's earnings have declined by 6% per year over the past 5 years.

Accelerating Growth: LNAP's earnings growth over the past year (57.6%) exceeds its 5-year average (-6% per year).

Earnings vs Industry: LNAP earnings growth over the past year (57.6%) exceeded the Healthcare industry 3.8%.

Return on Equity

High ROE: LNAP's Return on Equity (9.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/03/28 14:08
End of Day Share Price 2022/12/30 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LNA Santé SA is covered by 18 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Beatrice AllenBerenberg
Fraser DonlonBerenberg
Stephane SumarBNP Paribas Exane